about
Interaction of tumor cells with the microenvironmentFibulin-5 mutations link inherited neuropathies, age-related macular degeneration and hyperelastic skinPathobiology of wound healing after glaucoma filtration surgeryActivation of platelet-activating factor receptor exacerbates renal inflammation and promotes fibrosisAlternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across speciesPseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1.Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomas.The extracellular matrix at a glance.High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function.Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.Stiffness-activated GEF-H1 expression exacerbates LPS-induced lung inflammationTransforming growth factor-beta induces extracellular matrix protein cross-linking lysyl oxidase (LOX) genes in human trabecular meshwork cells.The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats.A general protease digestion procedure for optimal protein sequence coverage and post-translational modifications analysis of recombinant glycoproteins: application to the characterization of human lysyl oxidase-like 2 glycosylation.Focus on molecules: lysyl oxidaseLysyl oxidase, extracellular matrix remodeling and cancer metastasisBrief alcohol exposure alters transcription in astrocytes via the heat shock pathway.Left and right ventricle late remodeling following myocardial infarction in rats.Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.A tense situation: forcing tumour progression.Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage.SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.Lysyl Oxidase and the Tumor MicroenvironmentHuman copper-dependent amine oxidases.Engineering approaches to study fibrosis in 3-D in vitro systems.Diabetes-induced fibrotic matrix inhibits intramembranous bone healing.Lysyl Oxidase Induces Vascular Oxidative Stress and Contributes to Arterial Stiffness and Abnormal Elastin Structure in Hypertension: Role of p38MAPK.Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis.Inhibition of Lysyl Oxidases Impairs Migration and Angiogenic Properties of Tumor-Associated Pericytes.Developing novel anti-fibrotic therapeutics to modulate post-surgical wound healing in glaucoma: big potential for small molecules.Scientific Opinion on the substantiation of health claims related to copper and protection of DNA, proteins and lipids from oxidative damage (ID 263, 1726), function of the immune system (ID 264), maintenance of connective tissues (ID 265, 271, 17...Lysyl oxidase inhibition via β-aminoproprionitrile hampers human umbilical vein endothelial cell angiogenesis and migration in vitro.Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts.Lysyl oxidase (LOX) limits VSMC proliferation and neointimal thickening through its extracellular enzymatic activity
P2860
Q21245506-F5862979-B739-42B1-9B8A-3552A68F8C8DQ24595903-DC88896D-64A3-46CF-BF30-27F558F1813DQ28073856-388C64A5-897B-475B-98BE-849BDBAE1EFEQ28307191-90C82CDB-715A-4364-99BD-42160D4A0764Q28576808-7D0B833C-3F4F-40E6-AB5B-9A89175B6439Q33759171-DE5DB48F-1698-4F9B-B21D-CAF2072EBB86Q33847814-CCFC4458-A327-48F6-9498-3C9A5324DDCBQ34152843-4B3A7096-EED4-4B0A-9750-FA657A5C8924Q34355294-E611381C-5FBD-41AC-9013-B3899B7355FFQ34371559-05EDD3DC-8C87-433C-AA34-AE7F09792122Q35150381-2D78DEAA-D309-4822-87E4-C9332E9C8DAFQ35221416-A7F3CBE4-F674-4792-8F86-9E3B45DAC951Q35687138-6998F9A0-5FB6-4308-A324-5933BFC434D3Q35980499-BF73E801-8F42-4900-8239-9DC9F6C4E32FQ36020467-0086E725-34DF-4E10-A4C9-3152D5B095F6Q36284915-48934B0A-18AB-45E5-8DB3-F22DEA249EEDQ36713124-AD146ED1-848E-449F-B13B-13B287136D78Q36891606-A2D82DB6-6188-4065-9D85-8B1ED83A37A2Q36917969-4534CC06-0672-4A52-B3C3-6A9593993B9FQ37112264-E75D062A-F174-47EA-93B6-D328D223C2F8Q37225598-B31EFA8C-F5BF-48F7-8B63-C0601291F3B6Q37600466-64FD828F-C124-49C8-8F84-1B4212D6AD36Q37631469-5A8AFF8B-DF8F-46B4-A613-A8EE01F4CB0CQ38177145-A0CE6E13-7E99-4112-9591-1C3D2CC1A492Q38754809-A6CA5909-4D1E-4E3F-9C3C-58A46368F88BQ40096097-DDD04FF7-E18D-49E2-9772-EEFF418C4F58Q41466882-07828CE6-41DF-42D2-A9B3-80E65969AF19Q41977476-07B1ACEA-F869-4A77-B72C-96A8AF239B45Q42261768-19F2CD1A-D9EC-4776-8821-ADCB5503CE8FQ43192239-15DE02AA-1B7D-4446-8B37-8B0EF60ED9C7Q47147326-A47946AF-F239-4FDD-BDF5-9C2ED1C184FBQ48515363-4ED77985-F66F-41D9-A9F0-8ED1BC6FFC01Q53168403-A366013F-5640-4581-A769-1BF21DAC429BQ58763545-B8518324-7CC9-4C2E-AD56-5994D73E7F9D
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Lysyl oxidase as a potential therapeutic target
@ast
Lysyl oxidase as a potential therapeutic target
@en
Lysyl oxidase as a potential therapeutic target
@nl
type
label
Lysyl oxidase as a potential therapeutic target
@ast
Lysyl oxidase as a potential therapeutic target
@en
Lysyl oxidase as a potential therapeutic target
@nl
prefLabel
Lysyl oxidase as a potential therapeutic target
@ast
Lysyl oxidase as a potential therapeutic target
@en
Lysyl oxidase as a potential therapeutic target
@nl
P2093
P1476
Lysyl oxidase as a potential therapeutic target
@en
P2093
Antonio Rodríguez-Sinovas
Cristina Rodríguez
José Martínez-González
P304
P356
10.1358/DNP.2008.21.4.1213351
P407
P577
2008-05-01T00:00:00Z